🟢 Opus Genetics is trading 8.3% up in after-hours trading with no clear new catalyst

Opus Genetics is trading at $4.59, up 8.25%, in after-hours trading; available evidence does not establish a cause for the gain.

• The company announced a presentation at the Chardan Annual Healthcare Conference on October 20. Published at 7:00 a.m. ET, the announcement does not clearly explain the after-hours rise.
• No clear company-specific announcement tied to the move was found.
• The regular-session biotech backdrop was weak: XBI fell 2.01%, and external reporting also showed a decline.